Compounds > triazoles
Page last updated: 2024-08-24

triazoles and Movement Disorders

triazoles has been researched along with Movement Disorders in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ganjekar, S; Kilara, N; Mahendra, JV; Manjunatha, N; Srinivasa, R1
Bertorelli, R; Cohen-Williams, ME; Forlani, A; Foster, C; Fredduzzi, S; Higgins, GA; Hodgson, RA; Hunter, JC; Impagnatiello, F; Lachowicz, JE; Neustadt, BR; Nicolussi, E; Parker, EM; Parra, LE; Reggiani, A; Stamford, AW; Varty, GB; Zhai, Y1
Barodia, SK; Kumar, JB; Kumari, R; Luthra, PM; Mishra, CB; Prakash, A1
Egilmez, S; Itil, TM; Marasa, J; Polvan, N; Saletu, B1

Other Studies

4 other study(ies) available for triazoles and Movement Disorders

ArticleYear
Tardive dyskinesia associated with anastrozole.
    The Journal of neuropsychiatry and clinical neurosciences, 2013,Summer, Volume: 25, Issue:3

    Topics: Anastrozole; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma; Female; Humans; Middle Aged; Movement Disorders; Nitriles; Triazoles

2013
Characterization of the potent and highly selective A2A receptor antagonists preladenant and SCH 412348 [7-[2-[4-2,4-difluorophenyl]-1-piperazinyl]ethyl]-2-(2-furanyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine] in rodent models of movement
    The Journal of pharmacology and experimental therapeutics, 2009, Volume: 330, Issue:1

    Topics: Adenosine A2 Receptor Antagonists; Animals; CHO Cells; Cricetinae; Cricetulus; Depressive Disorder; Disease Models, Animal; Humans; Male; Mice; Movement Disorders; Neuroprotective Agents; Pyrimidines; Rats; Receptor, Adenosine A2A; Triazoles

2009
In silico study of naphtha [1, 2-d] thiazol-2-amine with adenosine A 2A receptor and its role in antagonism of haloperidol-induced motor impairments in mice.
    Neuroscience letters, 2009, Oct-09, Volume: 463, Issue:3

    Topics: Adenosine A2 Receptor Antagonists; Animals; Corpus Striatum; Dopamine; Haloperidol; Humans; Male; Mice; Models, Molecular; Motor Activity; Movement Disorders; Naphthalenes; Receptor, Adenosine A2A; Thiazoles; Triazoles

2009
Anxiolytic effects of a new triazolobenzodiazepine, U-31,889.
    Current therapeutic research, clinical and experimental, 1973, Volume: 15, Issue:9

    Topics: Adult; Animals; Anxiety; Behavior, Animal; Benzodiazepinones; Blood Circulation; Central Nervous System; Computers; Depression; Dogs; Electroencephalography; Female; Flurazepam; Humans; Hypnotics and Sedatives; Leukocyte Count; Male; Middle Aged; Movement Disorders; Respiration; Seizures; Sleep; Sleep Initiation and Maintenance Disorders; Tranquilizing Agents; Triazoles

1973